Samantha L. Hocking

384 Victoria Street
Sydney, NSW 2010, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 61 publications

Response to comment on '2025 ADS/ANZCA/GESA/NACOS clinical practice recommendations on the peri-procedural use of GLP-1/GIP receptor agonists'.

Response to comment on '2025 ADS/ANZCA/GESA/NACOS clinical practice recommendations on the peri-procedural use of GLP-1/GIP receptor agonists'.

Journal: Anaesthesia and intensive care

Published: August 14, 2026

A retrospective audit of weight loss and health outcomes following bariatric surgery at a tertiary public hospital.

A retrospective audit of weight loss and health outcomes following bariatric surgery at a tertiary public hospital.

Journal: Obesity research & clinical practice

Published: January 16, 2026

2025 ADS/ANZCA/GESA/NACOS clinical practice recommendations on the peri-procedural use of GLP-1/GIP receptor agonists.

2025 ADS/ANZCA/GESA/NACOS clinical practice recommendations on the peri-procedural use of GLP-1/GIP receptor agonists.

Journal: Anaesthesia and intensive care

Published: August 15, 2025

Improvement of Multifactorial Tremor in Klinefelter Syndrome With Testosterone Replacement Therapy.

Improvement of Multifactorial Tremor in Klinefelter Syndrome With Testosterone Replacement Therapy.

Journal: Case reports in endocrinology

Published: July 27, 2025

Minimum combined sleep, physical activity, and nutrition variations associated with lifeSPAN and healthSPAN improvements: a population cohort study.

Minimum combined sleep, physical activity, and nutrition variations associated with lifeSPAN and healthSPAN improvements: a population cohort study.

Journal: EClinicalMedicine

Published: June 13, 2025

Pharmacotherapy for the management of overweight and obesity.

Pharmacotherapy for the management of overweight and obesity.

Journal: Australian journal of general practice

Published: April 02, 2025

Targeting cardiometabolic risk in type 1 diabetes through incretin physiology.

Targeting cardiometabolic risk in type 1 diabetes through incretin physiology.

Journal: Trends in endocrinology and metabolism: TEM

Published: March 15, 2025

Assessment of metabolic dysfunction-associated fatty liver disease in primary care: a consensus statement summary.

Assessment of metabolic dysfunction-associated fatty liver disease in primary care: a consensus statement summary.

Journal: The Medical journal of Australia

Published: December 23, 2024

Understanding the Impact of Weight on Quality of Life and Willingness to Pay for Obesity Management in the APAC Region.

Understanding the Impact of Weight on Quality of Life and Willingness to Pay for Obesity Management in the APAC Region.

Journal: Clinical obesity

Published: October 11, 2024

Treatment of obesity: will incretin agonists make bariatric surgery a thing of the past?

Treatment of obesity: will incretin agonists make bariatric surgery a thing of the past?

Journal: Internal medicine journal

Published: September 01, 2024

SEC61B regulates calcium flux and platelet hyperreactivity in diabetes.

SEC61B regulates calcium flux and platelet hyperreactivity in diabetes.

Journal: The Journal of clinical investigation

Published: July 26, 2024

Challenges in achieving racial and ethnic health equity in type 2 diabetes: access to newer medications.

Challenges in achieving racial and ethnic health equity in type 2 diabetes: access to newer medications.

Journal: Lancet regional health. Americas

Published: May 06, 2024

Showing 1-12 of 61

Last Updated: 09/26/2026